Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Jason M. Heckert"'
Autor:
David C. Metz, Shria Kumar, Jason M. Heckert, Bryson W. Katona, Caroline Creamer, Alice Alderson, Bonita Bennett, Jennifer R. Eads, Sarit T. Kipnis, Daniel A. Pryma, David A. Mankoff, Michael C. Soulen, Samuel Botterbusch
Publikováno v:
Oncologist
Background Peptide receptor radionuclide therapy (PRRT) is effective for treating midgut neuroendocrine tumors (NETs); however, incorporation of PRRT into routine practice in the U.S. is not well studied. Herein we analyze the first year of PRRT impl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af39735e133fee8cc259faad6a15a413
https://doi.org/10.1634/theoncologist.2019-0743
https://doi.org/10.1634/theoncologist.2019-0743
Autor:
Hwan Lee, Sarit T. Kipnis, Michael C. Soulen, David A. Mankoff, Bryson W. Katona, Daniel A. Pryma, Jason M. Heckert, Jennifer R. Eads, Matthew L. Hung, Shria Kumar, David C. Metz, Bonita Bennett
Publikováno v:
JAMA Network Open
This cohort study examines laboratory, clinical, and survival outcomes among patients with gastroenteropancreatic neuroendocrine tumors (NETs) treated with peptide receptor radionuclide therapy.
Key Points Question What are the clinical outcomes
Key Points Question What are the clinical outcomes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e6d6f6c8bf711cc619ba3adad56e229
https://doi.org/10.1001/jamanetworkopen.2021.2274
https://doi.org/10.1001/jamanetworkopen.2021.2274